clofibrate has been researched along with Hypertrophy, Left Ventricular in 1 studies
angiokapsul: contains clofibrate & insoitolnicotinate
Hypertrophy, Left Ventricular: Enlargement of the LEFT VENTRICLE of the heart. This increase in ventricular mass is attributed to sustained abnormal pressure or volume loads and is a contributor to cardiovascular morbidity and mortality.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chuppa, S | 1 |
| Liang, M | 1 |
| Liu, P | 1 |
| Liu, Y | 1 |
| Casati, MC | 1 |
| Cowley, AW | 1 |
| Patullo, L | 1 |
| Kriegel, AJ | 1 |
1 other study available for clofibrate and Hypertrophy, Left Ventricular
| Article | Year |
|---|---|
MicroRNA-21 regulates peroxisome proliferator-activated receptor alpha, a molecular mechanism of cardiac pathology in Cardiorenal Syndrome Type 4.
Topics: Animals; Cardio-Renal Syndrome; Clofibrate; Disease Models, Animal; Fatty Acids; Fibrosis; Gene Expr | 2018 |